Specialized Media Development & Enhancers

Overview

Esco Aster provides specialized cell culture media development, optimization, benchmarking, and cost-reduction services across cell therapy, gene therapy, extracellular vesicles, and advanced biomanufacturing applications.

Our capabilities span from media formulation and ingredient qualification to process-specific optimization and commercial-scale media supply. We leverage qualified Asia-Pacific suppliers and alternative raw materials—from amino acids and growth factors to functional additives—to identify cost-effective alternatives without compromising critical performance attributes.

With a track record spanning cell based nutrition, cultivated meat, stem cells, virus/viral vector, secretomes, extracellular vesicles/exosomes.

Media development can be provided as a standalone service or integrated with our cell line creation, cell line development, process development, and biomanufacturing services, enabling media and cell/process parameters to be optimized together rather than independently.

Specialized Media Development

Esco Aster specializes in developing and optimizing media for both conventional and advanced 3D cell culture platforms, including our fixed packed bed Tide Motion bioreactor (adherent cells and derivatives) or TideWave™ bioreactor (immune cell and derivatives), suspension bioreactors in orbital format (10L) or stirred tank 500L (with or without microcarrier culture).

Our capabilities include: 

  • 3D cell culture media development optimized for high-density culture in Tide Motion bioreactors
  • Stem cell and MSC media development and optimization
  • Immune cell media development, including media designed for activation, expansion, selective enrichment, cryopreservation.
  • Selective media depletion and enrichment strategies for target immune cell populations, including NK cells and Tregs
  • Serum-free, chemically defined, animal-component-free media development
  • Media benchmarking against commercial and industry-standard formulations
  • Cost-down formulation through qualified alternative raw materials and regional sourcing
  • Media simplification and formulation optimization to improve manufacturability and supply-chain resilience

Media Cost-Down & Reformulation

Esco Aster can reformulate existing commercial or proprietary media to achieve a more competitive cost structure while maintaining the required biological performance.

Examples include:

  • Conversion of premium media into lower-cost, food-grade-equivalent formulations for cell-based nutrition.
  • Development of lower-cost medical-aesthetic-grade media for secretome and extracellular vesicle/exosome production
  • Conversion to animal-component-free, serum-free, chemically defined formulations
  • Optimization of stem cell media toward weekend-free or reduced-intervention culture workflows, reducing the need for frequent media changes and operator intervention

Media Enhancers & Cell Activation Systems

Beyond basal media development, Esco Aster develops functional media additives and process-specific enhancers designed to improve cell performance, productivity, recovery, and product quality.

Viral Vector & Virus Production

For high-density 3D viral production, excessive cellular stress and reactive oxygen species (ROS) generation can negatively affect cell health and viral productivity. Esco Aster develops virus-specific enhancement strategies designed to modulate cellular stress and improve viral productivity, where appropriate.

Potential applications include:

  • Viral titer enhancement through modulation of oxidative stress and ROS
  • Small-molecule strategies to modulate host-cell antiviral responses, supporting improved infection, transduction, or replication
  • Process-specific enhancers tailored to the virus type, host cell, and production platform


Exosome & Extracellular Vesicle Production

Esco Aster develops media and supplementation strategies tailored to the specific producer cell and desired extracellular vesicle profile, with objectives including:

  • Increasing extracellular vesicle/exosome productivity
  • Optimizing cell-specific secretion
  • Improving consistency and productivity during high-density culture
  • Supporting the development of scalable EV manufacturing processes

Cell Therapy & Immune Cell Applications

Our immune-cell media and enhancer capabilities include:

  • Immune cell activation and expansion
  • Enhancement of post-thaw cell viability and recovery
  • Optimization of cryopreservation and recovery conditions
  • Selective enrichment of target populations such as NK cells and Tregs
  • Development of functional supplementation strategies for T-cell reactivation, including approaches targeting anergic or exhausted T-cell states



Esco Aster Cell Culture Media Products

Esco Aster has developed the following cell cuture media products for specific production cell lines and applications, including:

  • Vero+ — optimized media platform for Vero cell applications with addition of ROS depleter for high cell density virus growth in 3D Tide Motion Bioreactors.
  • MDCK+ — optimized media platform for MDCK cell applications with addition of ROS depleter for high cell density virus growth in 3D Tide Motion Bioreactors.
  • Super+ — chemically defined animal component free media as serum-replacement designed to reduce dependence on conventional Fetal Bovine Serum with recombinant proteins for enhanced cell attachment for Tide Motion bioreactors.


From Formulation to Commercial Media Supply

Esco Aster can support the transition from laboratory-scale formulation to manufacturing-scale media supply, reducing the gap between media development and commercial implementation.

Our capabilities include:

Formulation → Benchmarking → Optimization → Raw Material Qualification → Scale-Up → Blending → Filling

For qualified formulations, Esco Aster can provide dry-powder blended media (made by qualified partners) as well as liquid media manufacturing and contract filling through our food-grade and clinical/ gmp grade manufacturing capabilities, with MOQ options from:

500ml or 1L liquid bottled media
RUO at 10L
GMP at 500L

2-5ml Vials Media Supplement:
RUO/GMP at 2L

Final volumes subject to formulation and product requirements.

Supporting Analytical & Functional Assays

Media development can be integrated with complementary analytical services to establish the relationship between media composition, cellular performance, and product output.

Related services include:

  • Real-Time Killing Assays using Incucyte® platforms
  • Spent Media Analysis using biochemical analyzers / BioAnalyzers
  • Flow Cytometry Assays for cell phenotype, viability, activation, and population characterization
  • Cell growth, viability, productivity, and functional assays
  • Comparative benchmarking against reference media and formulations
GMP Registration

Esco Aster can help as required to perform clinical study, trials, clinical development, register and file if needed to Usa DMF. Typical examples will be for IVF Media, Injectable grade cryopreservation.

GMP Storage/Cold Chain Logistics

Esco Aster can also provide cold chain storage and work with 3rd Party Logistics for point-to-point delivery within South Asia/Asean/Anz.

Integrated Media-to-cGMP/GMP

Esco Aster's key differentiation is the ability to develop media in the context of the entire bioprocess rather than as an isolated formulation exercise.

By combining media development with cell line development, 3D Tide Motion bioreactors, process development, analytical characterization, clinical development and cGMP manufacturing, we can optimize the interaction between cell, media, bioreactor, and process from the outset—helping clients achieve higher productivity, lower media costs, and a more scalable manufacturing process.